Beranda › Kanker Pankreas › Maryland › Baltimore
Uji klinis Kanker Pankreas di Baltimore, MD
31 studi untuk Kanker Pankreas mencari peserta di lokasi sekitar Baltimore (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Menerima pesertaFase 2
- Johns Hopkins University, Baltimore
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
Menerima pesertaFase 3
- Johns Hopkins University, Baltimore
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Menerima pesertaFase 2/3
- JHU Oncology Central Kit Services, Baltimore
- Johns Hopkins Hospital, Baltimore
- Oncology Investigational Drug Service (IDS), Baltimore
- dan 1 lainnya
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Menerima pesertaFase 3
- Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins & Sibley Memorial Hospital, Baltimore
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
Menerima pesertaFase 3
- University of Maryland School - Division of Hematology/Oncology, Baltimore
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Menerima pesertaFase 1/2
- The Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore
Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
Menerima pesertaStudi observasional
- The Johns Hopkins University School of Medicine, Baltimore
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Menerima pesertaFase 1
- Johns Hopkins, Baltimore
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Menerima pesertaFase 2
- Johns Hopkins Hospital, Baltimore
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
Menerima pesertaStudi observasional
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Total Pancreatectomy With Islet Autotransplantation (TPIAT) for High-Risk Patients With Pancreatic Tumors
Menerima peserta
- Johns Hopkins Hospital, Baltimore
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
Menerima pesertaFase 2
- Johns Hopkins University, Baltimore
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Menerima pesertaFase 3
- Sinai Hospital of Baltimore, Baltimore
Pancreatic Cancer Registry: For Any Person With a Personal or Family History
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Johns Hopkins Hospital, Baltimore
KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer
Menerima pesertaFase 1
- Sidney Kimmel Comprehensive Cancer Center, Baltimore
EXoPERT EMERALD Clinical Study
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- John Hopkins University, Baltimore
Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer
Menerima pesertaFase 1Sukarelawan sehat diterima
- Sidney Kimmel Comprehensive Cancer Center, Baltimore
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Menerima pesertaFase 1
- Johns Hopkins University, Baltimore
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Menerima pesertaFase 1/2
- Johns Hopkins Hospital, Baltimore
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
Menerima pesertaFase 3
- Sinai Hospital of Baltimore, Baltimore
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Menerima pesertaFase 1/2
- Johns Hopkins University, Baltimore
NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer
Menerima pesertaFase 2
- Sidney Kimmel Comprehensive Cancer Center, Baltimore
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Menerima pesertaFase 1/2
- Johns Hopkins University, Baltimore
Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts
Menerima pesertaStudi observasional
- The Johns Hopkins Hospital, Baltimore
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Menerima pesertaFase 2
- Ohio State University-Telemedicine, Baltimore
Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer
Menerima pesertaFase 1/2
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Towson · 8 mi jauhnya
The Cancer of the Pancreas Screening-5 CAPS5)Study
Menerima pesertaFase 3
- Johns Hopkins Hospital, Baltimore
Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions
Menerima pesertaStudi observasional
- The Johns Hopkins Hospital, Baltimore
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
Menerima pesertaFase 1/2
- Johns Hopkins, Baltimore
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
Menerima pesertaStudi observasional
- Johns Hopkins Hospital, Baltimore
Uji klinis Kanker Pankreas di kota lain
- Houston, TX61 studi
- New York City, NY60 studi
- Boston, MA43 studi
- Nashville, TN39 studi
- Los Angeles, CA35 studi
- St. Louis, MO33 studi
- Arlington, VA33 studi
- San Antonio, TX31 studi
- Philadelphia, PA26 studi
- Tampa, FL26 studi
- Durham, NC24 studi
- San Diego, CA24 studi
Studi lain di Baltimore
- Kanker Paru Non-Sel Kecil60 studi
- Kanker Payudara47 studi
- Kanker Prostat43 studi
- Kanker Paru40 studi
- Kanker (semua jenis)37 studi
- Kanker Kolorektal31 studi
- Kanker Metastatik28 studi
- Obesitas26 studi
- Kanker Kandung Kemih24 studi
- Gagal Jantung24 studi
- Kanker Ovarium22 studi
- Stroke21 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.